Key Takeaways
- Profit rebound, yield pressure persists: Consolidated net profit jumped 43% QoQ and 59% YoY to Rs. 86 crore, but equity yield fell ~7-8 bps for the full year and the drag from index/ETF growth continues.
- Market share gains driven by passives: Overall QAAUM market share rose to 5.89%, fueled by Index & ETF AUM growing ~33% YoY to Rs. 82,871 crore, while equity QAAUM grew only ~2%.
- Branch expansion bets on phygital: 29 new branches planned for FY24, targeting Tier 3/4 cities, with management calling it an "and" strategy alongside digital, expecting break-even in 1.5-2 years.
- International business under pressure: UTI International AUM declined due to fund maturities, IDEF redemptions, currency depreciation, and performance issues; a new US subsidiary has been formed to capture North American opportunities.
- What to watch next quarter: Whether equity yield stabilizes as guided, the pace of IDEF performance recovery, and any update on the BAF launch timeline.
Financial Performance
- Consolidated PAT surge: Q4 consolidated net profit of Rs. 86 crore was up 43% QoQ and 59% YoY, while FY23 consolidated net profit stood at Rs. 437 crore. Standalone PAT of Rs. 98 crore grew 31% YoY but declined 10% QoQ.
- Group AUM growth: UTI Group total AUM grew ~15.4% YoY to Rs. 15.56 lakh crore, supported by industry resilience and retail investor confidence.
- Employee cost containment: Group employee cost was Rs. 415 crore for FY23, up only 2% over FY22, with management guiding ~3.5% growth going forward and no 10-12% raise.
- Other expenses breakdown: The Rs. 16 crore QoQ increase included Rs. 4 crore CSR booked on actual outflow, Rs. 3 crore for a first-time all-India sales team meeting, Rs. 2.5 crore for digital initiatives and security, Rs. 1.5 crore in index fund subscription fees linked to AUM growth, Rs. 2 crore in higher PFRDA fees at UTI RSL, and Rs. 1.5 crore for additional Bloomberg terminals.
- UTI Capital loss: The alternatives business recorded a net loss of Rs. 3.3 crore due to investments in building the business, with total AUM of Rs. 1,707 crore across four funds.
- Payout ratio ambition: Management hopes to maintain or improve the 63.21% payout ratio from FY22, subject to board decisions.
Saha: "In 21 we have given 48% and in 22 we have raised it to 63.21% and we hope to maintain this payout ratio, or we'll improve it definitely."
AUM Composition & Yield Dynamics
- Passive-driven growth, equity lagging: UTI MF QAAUM grew 6.7% YoY versus the industry's 5.6%, but the composition was skewed: Index & ETFs grew ~33% YoY to Rs. 82,871 crore while Equity QAAUM grew only ~2% to Rs. 70,494 crore.
- SIP book steady: SIP AUM grew 17.5% YoY to Rs. 21,509 crore, with inflows up 12% YoY to Rs. 1,667 crore and 2.14 lakh new SIP accounts added. Average ticket size was Rs. 3,262.
- B30 penetration advantage: 22% of Monthly Average AUM came from B30 cities versus the industry's 17%, reflecting the company's geographical expansion focus.
- Yield decline mechanics: The marginal ~0.5 bps QoQ decline in overall yield was driven by a ~2 bps fall in equity category yield, caused by fresh inflows coming at lower yields and redemption of older higher-yield AUM. Weighted average AMC yield was 35 bps for Q4 and 37 bps for FY23.
- Equity yield trajectory: FY23 equity yield fell ~7-8 bps versus FY22. With ~80% of the equity/hybrid book now new AUM, yield should stabilize in FY24 barring significant redemption of older AUM, though ETF and index category growth will continue to drag overall yield down.
- Equity market share gap: Equity share of wallet is only 2.5% versus overall AUM market share of ~5%, which management attributes to fund performance, with a strategy to have 3-4 equity funds delivering superior returns to drive sales.
Lakhotia: "Unless there's a significant redemption on the older AUM, we should see some stabilization in the yield. But the overall yield will still have a drag-down effect because of the growth under the ETF and the index category."
International Business
- UTI International AUM decline: AUM fell to approximately Rs. 21,000 crore due to three factors: three Phoenix Funds maturing (~Rs. 6,000 crore), IDEF redemption pressure (~Rs. 2,000 crore, or 5.5-6% of the fund), currency depreciation (6-7%), and performance issues (17%). UTI has not yet redeemed its own seed capital.
- Flagship fund underperformance: IDEF AUM stood at USD 852 million, with the decline attributed to global growth stocks not performing well. Management expects a turnaround but gave no specific timeline.
- New US subsidiary formed: UTI International formed UTI Investments America to capture North American opportunities, with offices also opened in Paris. Some legal and hiring expenses are expected for the US market.
- Seed capital exposure: UTI initially invested USD 25 million in IDEF, with ~Rs. 7 crore repurchased. Management is waiting for an opportune moment to reduce exposure further.
Distribution & Branch Strategy
- 29 new branches in FY24: The expansion targets Tier 3/4 cities, with break-even expected in 1.5 to 2 years. Management emphasized this is not an either-or versus existing branches but an "and" strategy alongside digital.
- Branch rationalization to fund expansion: All branch offices will be rationalized in FY24, moving from larger offices to smaller ones (500-600 sq ft). Savings from this rationalization will largely fund the new branches, with only Rs. 3-4 crore net P&L impact expected.
- Three-pronged growth strategy: Top 8 cities as key focus, expansion beyond 30 cities into growing smaller markets, and a digital strategy with a 14-member team and state-of-art IT assets. All three "cylinders will be fired."
- Phygital rationale: Management argued India is still not completely digital, requiring a physical presence alongside digital channels to serve investors who want both modes.
Samsi: "This is not an either-or strategy. This is an 'and' strategy... India is still not completely digital. It's still a Phygital world where in India, people while they want to use digital mode, also look at physical mode. So you have to follow an and strategy."
Product & Regulatory Developments
- EPFO mandate won: UTI appointed as one of the asset managers for EPFO's investment in ETFs for a period of 3 years.
- CPSE policy tailwind: Central Public Sector Enterprises enabled a policy to continue investments in all Mutual Funds including UTI.
- BAF application submitted: An application for a Balanced Advantage Fund has been filed with SEBI, with approval expected close to the beginning of next quarter or end of this quarter.
- Hybrid fund outflows: Net outflows in the hybrid category were partly due to arbitrage funds being categorized under hybrid; pure hybrid net sales were flattish. Arbitrage funds saw redemption pressure due to the yield received.
- Digital assets relaunch: In final stages of re-launching superior digital assets including website and mobile app for partners and investors.
- Sustainability milestones: Published first sustainability report, received Green Energy certificate for using 100% renewable energy at the corporate office, formed an ESG Committee of the Board, and took SASB membership.
Cost Management & Investments
- Multi-year cost discipline: Management stated that for the last 6-7 years, the company has been outperforming inflation on cost management, with a targeted approach to optimize costs and ensure costs are not increased.
- Non-staff cost outlook: CSR expense will continue based on profit; one-time sales meet expenses will not recur; travel will continue; IT investment this year will be less than the previous year; NPS expense is variable.
- Digital team expansion: The 14-member digital team may add more data analysts, with continued investment in state-of-art IT and digital assets.
- UTI Capital fund launches planned: A series of fund launches including a Real Estate Opportunities Fund is being planned, with necessary documents being filed with regulators. No timeline specified.
Rahman: "We have especially targeted to basically optimize our costs and to ensure that the costs are not increased. If you recall our data, for the last 6-7 years we have been outperforming inflation. We will continue to do that, and we will keep you updated on the quarter-on-quarter basis as we go along to share with you our cost management strategy."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Branch expansion | Open 29 new offices in Tier 3/4 cities | FY24 |
| Branch break-even | New branches to break even | 1.5 to 2 years |
| Branch rationalization | Rationalize all branch offices to smaller spaces; net P&L impact Rs. 3-4 crore | FY24 |
| Staff cost growth | Grow at ~3.5%; no 10-12% raise | FY24 |
| BAF launch | Balanced Advantage Fund approval and launch | End of current quarter or early next quarter |
| Payout ratio | Maintain or improve 63.21% payout ratio | Ongoing, subject to board |
| Cost management | Continue to outperform inflation | Ongoing |
| Yield stabilization | Equity yield to stabilize barring significant older AUM redemption; overall yield still dragged by ETF/index growth | FY24 |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Consolidated net profit | ₹86 crore, +43% QoQ and +59% YoY |
| Standalone PAT (UTI AMC Ltd) | ₹98 crore, +31% YoY and -10% QoQ |
| Consolidated net profit (FY23) | ₹437 crore |
| UTI Group total AUM | ₹15.56 lakh crore, +15.4% YoY |
| UTI MF quarterly average AUM | ₹2,38,791 crore, +6.7% YoY vs industry +5.6% |
| UTI MF market share | 5.89% for the quarter |
| Weighted average AMC yield | 35 bps for the quarter, 37 bps for FY23 |
| Equity QAAUM | ₹70,494 crore, +~2% YoY |
| Index & ETFs QAAUM | ₹82,871 crore, +~33% YoY |
| Net sales (FY23) | ₹1,208 crore |
| ETFs & Index Funds net inflows | ₹1,100 crore |
| Hybrid funds net outflow | ₹719 crore for the quarter |
| SIP AUM | ₹21,509 crore, +17.5% YoY |
| SIP inflows for the quarter | ₹1,667 crore, +12% YoY; average ticket size ₹3,262 for March 2023 |
| Live SIP folios | 25.2 lakh, added 2.14 lakh new SIP accounts in the quarter |
| Live folios | 1.22 crore, added 36,000 in the quarter |
| B30 MAAUM share | 22% of Monthly Average AUM for March 2023 vs industry 17% |
| Market share of gross sales | 8.5% during Q4 |
| UTI RSL AUM | ₹2,40,709 crore, +~19.2% YoY; 26.78% share of industry AUM |
| UTI RSL PAT | ₹46 crore, +~10% YoY |
| UTI International AUM | ₹21,703 crore as of 31st March 2023 |
| UTI International management fees | ₹129 crore, +1.6% YoY |
| UTI Capital total AUM | ₹1,707 crore |
| UTI Capital net loss | ₹3.3 crore due to investments to build the business |
| Group employee cost (Q4 FY23) | ₹107 crore, -7% YoY |
| Group employee cost (FY23) | ₹415 crore, +2% over FY22 |
| Other expenses | ₹72 crore, up from ₹56 crore in Q3; includes ₹4 crore CSR, ₹3 crore sales meet, ₹2.5 crore digital/security, ₹1.5 crore index subscription fees, ₹2 crore PFRDA fees, ₹1 crore SASB/sustainability, ₹1.5 crore Bloomberg |
| Payout ratio (FY22) | 63.21%, up from 48% in FY21 |